1QDD

CRYSTAL STRUCTURE OF HUMAN LITHOSTATHINE TO 1.3 A RESOLUTION

Summary for 1QDD

Entry DOI	10.2210/pdb1qdd/pdb
Related	1LIT
Descriptor	LITHOSTATHINE, beta-D-galactopyranose-(1-3)-[N-acetyl-alpha-neuraminic acid-(2-6)]2-acetamido-2-deoxy-alpha-D-glucopyranose (3 entities in total)
Functional Keywords	pancreatic stone inhibitor, lithostathine, metal binding protein
Biological source	Homo sapiens (human)
Total number of polymer chains	1
Total formula weight	16879.52
Authors	Gerbaud, V.,Pignol, D.,Loret, E.,Bertrand, J.A.,Berland, Y.,Fontecilla-Camps, J.C.,Canselier, J.P.,Gabas, N.,Verdier, J.M. (deposition date: 1999-05-20, release date: 1999-05-28, Last modification date: 2021-11-03)
Primary citation	Gerbaud, V.,Pignol, D.,Loret, E.,Bertrand, J.A.,Berland, Y.,Fontecilla-Camps, J.C.,Canselier, J.P.,Gabas, N.,Verdier, J.M. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine. J.Biol.Chem., 275:1057-1064, 2000 Cited by PubMed: 10625646 DOI: 10.1074/jbc.275.2.1057 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.3 Å)

Structure validation